KTTA icon

Pasithea Therapeutics

8 hedge funds and large institutions have $985K invested in Pasithea Therapeutics in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, reducing their positions, and 2 closing their positions.

Holders
8
Holders Change
+1
Holders Change %
+14.29%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
KPF
1
K2 Principal Fund
Ontario, Canada
$715K 550,000
Citadel Advisors
2
Citadel Advisors
Florida
$95K 72,937 +72,937 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$74K 56,583 +43,883 +346%
MSFP
4
Mark Sheptoff Financial Planning
Connecticut
$62K 48,000 +48,000 New
TSS
5
Two Sigma Securities
New York
$25K 18,899 +18,899 New
BlackRock
6
BlackRock
New York
$13K 9,962 +1,460 +17%
JPMorgan Chase & Co
7
JPMorgan Chase & Co
New York
$1K 1,000
TRCT
8
Tower Research Capital (TRC)
New York
-29,385 Closed
HF
9
HRT Financial
New York
-12,731 Closed
CFGS
10
Concourse Financial Group Securities
Alabama
Wells Fargo
11
Wells Fargo
California
$0 84 +54 +180%